NYSE:AHR
American Healthcare REIT, Inc.
A US-based REIT focused on owning and leasing high-quality healthcare properties to hospitals, clinics, and senior living operators nationwide.
Key Metrics
Investment Thesis
Bull Case
AHR offers exposure to the resilient healthcare sector with improving fundamentals evidenced by a return to profitability in 2025 and consistent revenue expansion over the last five years. The shift from net losses to positive net profit suggests successful deleveraging or operational efficiency improvements that could support future dividend sustainability.
Bear Case
Investors should be cautious due to the substantial retained earnings deficit of -$1.56B and significant non-operating losses totaling -$450.3M which may indicate underlying structural issues. Heavy reliance on financing activities with revolver repayments exceeding proceeds suggests potential liquidity pressure in a high-interest rate environment.
About American Healthcare REIT, Inc.
American Healthcare REIT (AHR) specializes in acquiring, developing, and operating healthcare properties across the United States, serving hospitals, physician groups, and senior living facilities. The company generates revenue primarily through long-term lease agreements with institutional tenants in a stable market sector. AHR leverages its extensive real estate portfolio to provide essential infrastructure for the evolving healthcare landscape.
Analysis
Management Discussion
The company achieved a significant turnaround in 2025 with net profit of $70.8M compared to losses in previous years, driven by revenue growth from $1.41B in 2022 to $2.26B in 2025. This profitability was supported by strong operating cash flow of $294.4M and substantial financing inflows, though the entity continues to manage a significant retained earnings deficit of -$1.56B.
Industry Overview
The healthcare real estate sector is characterized by long lease terms and high barriers to entry, offering defensive characteristics often uncorrelated with broader economic cycles. Demand remains robust due to aging demographics and the continuous need for medical infrastructure, though valuation sensitivity to interest rates remains a critical factor for REITs.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $1.41B | $1.67B | $1.88B | $2.26B |
| Cost of Revenue | $1.28B | $1.50B | $1.65B | $1.79B |
| Gross Profit | $130.6M | $166.4M | $229.9M | $466.6M |
| Operating Expenses | $-171.3M | $-140.4M | $-133.6M | $51.4M |
| Operating Income | $302.0M | $306.8M | $363.5M | $415.2M |
| G&A | $43.4M | $47.5M | $47.6M | $58.7M |
| Stock-Based Comp | $3.9M | $5.5M | $9.9M | $14.6M |
| D&A | $168.0M | $182.6M | $179.2M | $187.6M |
| Depreciation | $141.3M | $147.6M | $151.3M | $156.4M |
| Amortization | $28.4M | $46.6M | $28.0M | $30.3M |
| Other OpEx | $-214.8M | $-187.9M | $-181.2M | $-7.3M |
| Non-Operating Income | $-374.8M | $-383.1M | $-397.4M | $-366.5M |
| Interest Expense | $106.0M | $163.2M | $127.7M | $85.8M |
| Pre-Tax Income | $-72.8M | $-76.2M | $-33.9M | $48.6M |
| Income Tax | $586.0K | $663.0K | $1.7M | $-22.2M |
| Continuing Ops | $-73.4M | $-76.9M | $-35.6M | $70.8M |
| Discontinued Ops | $0 | $0 | $0 | $0 |
| Net Income | $-73.4M | $-76.9M | $-35.6M | $70.8M |
| Minority Interest | $7.9M | $-5.4M | $2.2M | $1.0M |
| Net to Common | $-81.3M | $-71.5M | $-37.8M | $69.8M |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $65.1M | $43.4M | $76.7M | $114.8M |
| Inventory | $19.8M | $19.5M | $19.5M | $18.8M |
| Intangibles | $236.3M | $180.5M | $161.5M | $253.2M |
| Goodwill | $231.6M | $234.9M | $234.9M | $234.9M |
| Operating Leases | $276.3M | $227.8M | $164.0M | $135.4M |
| Total Assets | $4.79B | $4.58B | $4.49B | $5.43B |
| Total Liabilities | $3.14B | $3.12B | $2.18B | $2.07B |
| Shareholders' Equity | $1.65B | $1.46B | $2.30B | $3.36B |
| Paid-In Capital | $2.54B | $2.55B | $3.72B | $4.88B |
| Retained Earnings | $-1.14B | $-1.28B | $-1.46B | $-1.56B |
| AOCI | $-2.7M | $-2.4M | $-2.5M | $-2.1M |
| Total L&E | $4.79B | $4.58B | $4.49B | $5.43B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $-73.4M | $-76.9M | $-35.6M | $70.8M |
| Non-Cash Adjustments | $218.7M | $158.6M | $211.4M | $162.0M |
| Working Capital Changes | $2.4M | $16.8M | $320.0K | $61.7M |
| Cash from Operations | $147.8M | $98.5M | $176.1M | $294.4M |
| Cash from Investing | $-118.6M | $9.4M | $-8.7M | $-1.08B |
| Share Buybacks | $20.7M | $469.0K | $14.0K | $0 |
| Dividends Paid | $51.1M | $76.3M | $120.9M | $163.5M |
| Cash from Financing | $-42.9M | $-129.1M | $-134.7M | $817.2M |
| FX Effect | $154.0K | $7.0K | $-91.0K | $62.0K |
| Net Change in Cash | $-13.7M | $-21.1M | $32.6M | $28.4M |
| Beginning Cash | $125.5M | $111.9M | $90.8M | $123.3M |
| Ending Cash | $111.9M | $90.8M | $123.3M | $151.8M |
Frequently Asked Questions
How does American Healthcare REIT, Inc. make money?
Hospital Properties, Physician Office Buildings, Senior Living Facilities, and Other Healthcare Real Estate Assets
What are the main risks for AHR?
Interest rate volatility impacting debt servicing costs and property valuations, potential shifts in government healthcare reimbursement policies affecting tenant creditworthiness, rising construction costs hindering expansion plans, and economic downturns leading to higher vacancy rates or lease defaults.
What is AHR's competitive advantage?
Diversified geographic footprint reducing regional concentration risk, long-term lease structures providing stable cash flow, and specialized expertise in healthcare real estate design and tenant relations.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.